Professional Documents
Culture Documents
KennedyS MIS690 Week 7 Collaborative Learning Community Q6
KennedyS MIS690 Week 7 Collaborative Learning Community Q6
Stephen Kennedy
This study source was downloaded by 100000796415555 from CourseHero.com on 05-30-2022 03:22:21 GMT -05:00
https://www.coursehero.com/file/86273579/KennedyS-MIS690-Week-7-Collaborative-Learning-Community-Q6docx/
WEEK 7 CLC ASSIGNMENT 2
Question 6:
When conducting a cost benefit analysis, we analyze decisions, systems, and projects,
and establish value for intangibles through assessment of associated costs and benefits. This will
help in developing conclusions around the advisability and feasibility of the project
evidence-based assessments of the model absent external factors like opinions and bias, and an
1. What are model deployment costs? Research and describe two similar models for cost
benchmarks.
2. What is a proposed task and timeline for deploying your model? Create a schedule using
MS Project 2016 or another free software app.
3. What specific training will be required for those who will be using the model on a regular
basis? Be sure to review and reference the Topic 7 study materials related to models.
4. Can this model be used on a repetitive basis? Explain.
5. How will model quality be tracked over time? Be sure to review and reference the Topic
7 study materials related to models.
6. What specific benefits to the organization will be realized over time as a result of using
the model? Be sure to review and reference the Topic 7 study materials that cover cost and
benefit analysis.
accurate view of consequences of the model implementation in preparation for strategic business
operations at IHS.
Effects on Stakeholders and Participants - It is expected that the stakeholders are going to
understand the relationship between the cash being spent in marketing and sensitization for IHS
and enrollments at 65 for beneficiaries of Medicare and Medicaid, and how it impacts the
revenue stream of IHS. There are data analysis problems that are tied to the business problem
and understanding these can help to better analyze where there is wastage in costs. The costs for
This study source was downloaded by 100000796415555 from CourseHero.com on 05-30-2022 03:22:21 GMT -05:00
https://www.coursehero.com/file/86273579/KennedyS-MIS690-Week-7-Collaborative-Learning-Community-Q6docx/
WEEK 7 CLC ASSIGNMENT 3
the population include actual cost of healthcare delivery, inpatient treatment, and hospitalization
costs in terms of stays and days, normal hospital and departmental visits be beneficiaries, tests
and imaging costs, E&M costs, procedure actual costs, and outpatient costs. If the stakeholders
evaluate these costs and compare the revenue stream, enrollments, and health outcomes of the
patients enrolled into IHS and find that there are high-level benefits that accrue over the lifetime
of the project, that is the Medicare and Medicaid enrollments over the long run, then the benefits
can be summed up to establish the possible feasibility and advisability of the project. The model
is a good tool for establishing the linear regressions and relationships between inputs and outputs
of the program, thus making it possible to determine the best direction to take to cut costs.
Social Benefits – Patients from the target population would be assessed for instances of
negative feedback from treatment procedures, which can then be used as a qualitative measure
for the new direction taken with IHS pending evaluation of the effectiveness of the model since
the ultimate goal would be to increase effectiveness of treatments while reducing costs. The
target would be to restore the costs to a 100% marginal cost from the current 130% marginal cost
resulting form the 30% increase recorded in the last five years. The social benefits would be
established through reduced return visits that would otherwise increase costs in outpatient and
other departmental and general hospital admission or treatment charges. Imaging and tests would
be appraised for quality and immediacy so that the treatment process can be hastened, and
medical procedures started early with the support of evidence-based data analyses.
Appraising Desirability – If the model creates a plan that promotes faster treatment and
reductions in costs, then the next step would be to run the model over in different setting and for
This study source was downloaded by 100000796415555 from CourseHero.com on 05-30-2022 03:22:21 GMT -05:00
https://www.coursehero.com/file/86273579/KennedyS-MIS690-Week-7-Collaborative-Learning-Community-Q6docx/
WEEK 7 CLC ASSIGNMENT 4
Weighing the Investment Opportunities – It would be tested for scalability and validity
through the model evaluation stage (Smartsheet.com, 2021), and following evaluation of
outcomes, and if found to provide positive result, can be utilized across other business areas like
Assessing the Change Initiatives – I anticipate that the change would be in the form of a
policy change that impacts Medicare providers, suppliers, and participants so that they are
required to appraise their services and ensure that patients within the target population receive
Part A and Part B coverage at affordable costs, and that data is available for participants whose
services do not accept Medicare assignment are screened from among the approved TPAs.
Patients would be advised to crosscheck their healthcare providers with the use of
Medicare.gov’s Physician Compare Tool so that they seek services preferably from doctors
participating in Medicare program. The policy would also require changes in individual
providers and facilities that are Medicare assigned so as to qualify as a preferred provider to run
the program. This would be possible as a result of the data analysis conducted using the model.
Developing Benchmarks for Other Models – Comparing the outputs over the long-run
can be possible for three different models proposed in the model development phase to establish
which one gives the best predictions and analysis of historical data to easy decision-making
based on the outputs and predictions. The final step could be to final decision-making on which
model to pursue to increase the efficiency of the business operations at IHS. Any risks associated
with the model would be outlined at the initial implementation of the model so that any
discrepancies in the data may be noted early and corrected while observing changes in healthcare
outcomes and program outcomes (Smartsheet.com, 2021). A final point worth noting is that
healthcare procedures do not affect participants in a similar manner, and the sensitivity of the
This study source was downloaded by 100000796415555 from CourseHero.com on 05-30-2022 03:22:21 GMT -05:00
https://www.coursehero.com/file/86273579/KennedyS-MIS690-Week-7-Collaborative-Learning-Community-Q6docx/
WEEK 7 CLC ASSIGNMENT 5
changes and alterations may not be easy to assess (Smartsheet.com, 2021). The only possible
outcomes. Additionally, revenue and costs are moving targets that are determined by activities
like external variables outside the program’s or physician’s control. Therefore, accuracy based on
costs, revenue and cash flow, and value may not be possible since we would be dealing with
uncertainties that are tied to human activities and human elements. The long-run benefits and
costs would be a better measure of cost-benefit analysis for IHS (Smartsheet.com, 2021).
This study source was downloaded by 100000796415555 from CourseHero.com on 05-30-2022 03:22:21 GMT -05:00
https://www.coursehero.com/file/86273579/KennedyS-MIS690-Week-7-Collaborative-Learning-Community-Q6docx/
WEEK 7 CLC ASSIGNMENT 6
References
https://www.smartsheet.com/expert-guide-cost-benefit-analysis
This study source was downloaded by 100000796415555 from CourseHero.com on 05-30-2022 03:22:21 GMT -05:00
https://www.coursehero.com/file/86273579/KennedyS-MIS690-Week-7-Collaborative-Learning-Community-Q6docx/
Powered by TCPDF (www.tcpdf.org)